Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10/CXCR3 to boost antitumor immunity.

Cell Prolif · 2025 · PMC11693575 · PMID 39219056

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The combination therapy group showed no statistically significant variance in CD8 + T cells compared to the oHSV group, showing a decreasing trend (Figure S6C,D ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.